Discontinued — last reported Q2 '18
Other
Fair Value Measurement Disclosure
Merck & Co. Fair Value Measurement Disclosure decreased by 34.1% to $324.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.1%, from $345.00M to $324.00M. Over 3 years (FY 2022 to FY 2025), Fair Value Measurement Disclosure shows a downward trend with a -9.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ2 2018
How to read this metric
Higher levels indicate a larger portion of the balance sheet is subject to market-based valuation volatility.
Detailed definition
This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring o...
Peer comparison
Standard disclosure for financial institutions with significant investment holdings.
Metric ID:
fair_value_measurement_disclosureHistorical Data
11 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $433.00M | $176.00M | $239.00M | $167.00M | $142.00M | $298.00M | $345.00M | $268.00M | $855.00M | $492.00M | $324.00M |
| QoQ Change | — | -59.4% | +35.8% | -30.1% | -15.0% | +109.9% | +15.8% | -22.3% | +219.0% | -42.5% | -34.1% |
| YoY Change | — | — | -44.8% | — | — | +69.3% | +44.4% | +60.5% | +502.1% | +65.1% | -6.1% |
Range$142.00M – $855.00M
CAGR-11.0%
Avg YoY Growth+98.6%
Median YoY Growth+60.5%
Current Streak2 quarters decline
Fair Value Measurement Disclosure at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s fair value measurement disclosure?
- Merck & Co. (MRK) reported fair value measurement disclosure of $324.00M in Q4 2025.
- How has Merck & Co.'s fair value measurement disclosure changed year-over-year?
- Merck & Co.'s fair value measurement disclosure decreased by 6.1% year-over-year, from $345.00M to $324.00M.
- What is the long-term trend for Merck & Co.'s fair value measurement disclosure?
- Over 3 years (2022 to 2025), Merck & Co.'s fair value measurement disclosure has grown at a -9.2% compound annual growth rate (CAGR), from $433.00M to $324.00M.
- What does fair value measurement disclosure mean?
- The total value of assets and liabilities reported at current market prices.